Market Overview

The Prostate Specific Antigen (PSA) Testing market is predicted to develop at a compound annual growth rate (CAGR) of 12.10% from 2024 to 2033, when it is projected to reach USD 9.12 billion, based on an average growth pattern. The market is estimated to reach a value of USD 3.46 billion in 2024.

SOURCE: We Market Research

A blood test called prostate-specific antigen (PSA) testing is used to screen for prostate cancer and track its advancement. A protein called PSA, which aids in liquefying semen, is produced by the prostate gland. Increased PSA values can be a sign of several prostate problems, including cancer. PSA testing has limits even if it's a useful tool for early cancer detection. This is because elevated levels can also be caused by diseases other than cancer. It is possible for there to be false positives or negatives, which could result in overtreatment or missed diagnosis. In order to provide accurate assessment and well-informed decision-making regarding prostate health, its interpretation necessitates careful thought and frequently involves additional diagnostic techniques, such as biopsies.

There are various important factors are driving the market for prostate-specific antigen (PSA) testing are, there is a growing need for PSA testing due to rising awareness and proactive healthcare programs for early cancer diagnosis. Furthermore, an increase in the prevalence of prostate-related problems brought on by an aging global population, especially in industrialized nations, is driving the market. Adoption is accelerated by technological developments in diagnostic methods and the creation of more precise and sensitive PSA tests, which improve accuracy. Additionally, an increase in research and development efforts together with the global incidence of prostate cancer serve to further drive market expansion. Together, these elements foster innovation, market growth, and increased accessibility to PSA testing, which helps to shape the market's future.

Market Scope

Prostate Specific Antigen (PSA) Testing Industry: Dynamics & Restrains

Market Drivers

Rising Prevalence of Prostate Cancer - The growing incidence of prostate cancer is a major driver behind the growth of the prostate specific antigen (PSA) testing market. PSA testing is becoming more popular as a result of the growing urge for early detection and surveillance brought on by the rising incidence of prostate cancer worldwide. PSA testing is a crucial diagnostic method that provides early treatment options and is capable of detecting prostate cancer. The market for PSA testing has grown significantly as a result of the pressing demand for efficient screening techniques due to the rising incidence of prostate cancer. This development is also significantly influenced by the knowledge of and emphasis on early diagnosis.

Rising Patient Preference for Early Diagnosis - Patients' increasing need for early diagnosis is driving significant increase in the market for prostate specific antigen (PSA) testing. People are actively searching for preventive healthcare measures as they become more conscious of the significance of early detection in enhancing treatment outcomes. In line with patients' preferences for prompt therapies, PSA testing appears as a critical tool in enabling early identification of prostate cancer. Healthcare providers are increasingly incorporating PSA testing into routine screenings to meet the growing demand from patients for early detection and improved prognosis among individuals at risk of prostate cancer. This drive for quick and accurate diagnostic methods is driving the market expansion.

Market restrains

Controversies Surrounding Overdiagnosis and Overtreatment - Prostate specific antigen (PSA) testing industry expansion is being hindered by disagreements around overdiagnosis and overtreatment. Those who disagree assert that treatments that are dangerous and ineffective could be the result of elevated PSA levels. Fears about unnecessary medical treatments and false positives have made both patients and healthcare practitioners cautious. As a result, there is resistance in the market from those who question PSA testing's overall efficacy. Weighing the benefits and drawbacks of testing becomes essential because it influences decision-making and keeps PSA testing from being universally recognized as a reliable tool. This highlights the ongoing challenge of finding a cautious balance between early identification and potential overtreatment.

We Market Research: Prostate Specific Antigen (PSA) Testing Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Prostate Specific Antigen (PSA) Testing Segmentation

Market- By Test Procedure Analysis

By Test Procedure, the Prostate Specific Antigen (PSA) Testing Market is Categories into Preliminary Tests, Confirmatory Tests. The Preliminary Tests segment accounts for the largest share of around 62% in 2024.

The ability to quickly screen people for possible prostate problems is propels the preliminary tests subsegment of the prostate specific antigen (PSA) testing market. These tests function as early indicators, allowing for immediate diagnosis and further diagnoses in the future.

The following segments are part of an in-depth analysis of the global Prostate Specific Antigen (PSA) Testing market:

Prostate Specific Antigen (PSA) Testing Industry: Regional Analysis

North America Market Forecast

North America dominate the Prostate Specific Antigen (PSA) Testing Market with the highest revenue generating market with share of more than 46%. Due to a strong healthcare system and increased cancer awareness, North America has a thriving PSA testing market. Although current discussions about overdiagnosis, government programs support early detection. Proactive screening for prostate cancer fuels market development, but cost concerns provide challenges.

Europe Market Statistics

Europe is the second-largest market for Prostate Specific Antigen (PSA) Testing. Due to an older population and well-established healthcare infrastructures, Europe is showing signs of a developing PSA testing market. To guarantee successful screening procedures, a balanced strategy is needed to handle the problems posed by strict laws addressing false positives and ethical issues.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing market for Prostate Specific Antigen (PSA) Testing during the forecast period. The Asia-Pacific area has seen an increase in the demand for PSA testing as a result of increased rates of prostate cancer and bettering healthcare facilities. Screening rates are affected by cultural and awareness gaps, though, and for the market to continue growing, focused education campaigns and standardized testing procedures are required.

Key Market Players

The Prostate Specific Antigen (PSA) Testing Market is dominated by a few large companies, such as

·         Abbott Laboratories

·         Beckman Coulter

·         Bio-Rad Laboratories, Inc.

·         F. Hoffmann-La Roche Ltd.

·         Ortho Clinical Diagnostics

·         Siemens Healthineers AG

·         Danaher Corporation

·         Mindray Medical International Limited

·         Alere Inc.

·         Quidel Corporation

·         Others

1.      Global Prostate Specific Antigen (PSA) Testing Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Prostate Specific Antigen (PSA) Testing Market Scope and Market Estimation

1.2.1. Global Prostate Specific Antigen (PSA) Testing Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2033)

1.2.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033

1.3.    Market Segmentation

1.3.1. Component of Global Prostate Specific Antigen (PSA) Testing Market

1.3.2. Technology of Global Prostate Specific Antigen (PSA) Testing Market

1.3.3. Assays type of Global Prostate Specific Antigen (PSA) Testing Market

1.3.4. Region of Global Prostate Specific Antigen (PSA) Testing Market

2.      Executive Summary

2.1.    Global Prostate Specific Antigen (PSA) Testing Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Prostate Specific Antigen (PSA) Testing Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Prostate Specific Antigen (PSA) Testing Market Estimates & Historical Trend Analysis (2019 - 2022)

4.      Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by TEST PROCEDURE

4.1.    Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by TEST PROCEDURE, 2019 to 2033

4.1.1. Preliminary Tests

4.1.2. Confirmatory Tests

5.      Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Test Type

5.1.    Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Test Type, 2019 to 2033

5.1.1. Total Prostate Specific Antigen Test (tPSA)

5.1.2. Complex Prostate Specific Antigen Test (cPSA)

5.1.3. Free Prostate Specific Antigen Test (fPSA)

5.1.4. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR)

5.1.5. PCA3Test

5.1.6. Trans-rectal Ultrasound

5.1.7. Biopsy

6.      Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Assays type

6.1.    Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Assays type, 2019 to 2033

6.1.1. Radioimmunoassay (RIA)

6.1.2. Enzyme Immunoassay (EIA)

7.      Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by APPLICATION

7.1.    Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Assays type, 2019 to 2033

7.1.1. Screening

7.1.2. Post-treatment Monitoring

8.      Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2033

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis

9.1.    North America Prostate Specific Antigen (PSA) Testing Market Assessments & Key Findings

9.1.1. North America Prostate Specific Antigen (PSA) Testing Market Introduction

9.1.2. North America Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

9.1.2.1.   By TEST PROCEDURE

9.1.2.2.   By Test Type

9.1.2.3.   By Assays type

9.1.2.4.   By APPLICATION

9.1.2.5.   By Country

9.1.2.5.1.     The U.S.

9.1.2.5.2.     Canada

9.1.2.5.3.     Mexico

10.  Europe Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis

10.1.  Europe Prostate Specific Antigen (PSA) Testing Market Assessments & Key Findings

10.1.1.   Europe Prostate Specific Antigen (PSA) Testing Market Introduction

10.1.2.   Europe Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

10.1.2.1.    By TEST PROCEDURE

10.1.2.2.    By Test Type

10.1.2.3.    By Assays type

10.1.2.4.    By APPLICATION

10.1.2.5.    By Country

10.1.2.5.1. Germany

10.1.2.5.2. U.K.

10.1.2.5.3. France

10.1.2.5.4. Italy

10.1.2.5.5. Spain

10.1.2.5.6. Russia

10.1.2.5.7. Rest of Europe

11.  Asia Pacific Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Prostate Specific Antigen (PSA) Testing Market Introduction

11.1.2.   Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

11.1.2.1.    By TEST PROCEDURE

11.1.2.2.    By Test Type

11.1.2.3.    By Assays type

11.1.2.4.    By APPLICATION

11.1.2.5.    By Country

11.1.2.5.1. China

11.1.2.5.2. Japan

11.1.2.5.3. India

11.1.2.5.4. Australia

11.1.2.5.5. South Korea

11.1.2.5.6. ASEAN

11.1.2.5.7. Rest of Asia Pacific

12.  Middle East & Africa Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Introduction

12.1.2.   Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

12.1.2.1.    By TEST PROCEDURE

12.1.2.2.    By Test Type

12.1.2.3.    By Assays type

12.1.2.4.    By APPLICATION

12.1.2.5.    By Country

12.1.2.5.1. U.A.E.

12.1.2.5.2. Saudi Arabia

12.1.2.5.3. Egypt

12.1.2.5.4. South Africa

12.1.2.5.5. Rest of Middle East & Africa

13.  South America Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Prostate Specific Antigen (PSA) Testing Market Introduction

13.1.2.   South America Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

13.1.2.1.    By TEST PROCEDURE

13.1.2.2.    By Test Type

13.1.2.3.    By Assays type

13.1.2.4.    By APPLICATION

13.1.2.5.    By Country

13.1.2.5.1. Brazil

13.1.2.5.2. Argentina

13.1.2.5.3. Colombia

13.1.2.5.4. Rest of South America

14.  Competition Landscape

14.1.  Global Prostate Specific Antigen (PSA) Testing Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Prostate Specific Antigen (PSA) Testing Market Competition White Space Analysis, By Assays type

14.3.  Global Prostate Specific Antigen (PSA) Testing Market Competition Heat Map Analysis, By Assays type

14.4.  Global Prostate Specific Antigen (PSA) Testing Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     Abbott Laboratories

15.1.1.   Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

15.2.      Beckman Coulter

15.3.      Bio-Rad Laboratories, Inc.

15.4.      F. Hoffmann-La Roche Ltd.

15.5.      Ortho Clinical Diagnostics

15.6.      Siemens Healthineers AG

15.7.      Danaher Corporation

15.8.      Mindray Medical International Limited

15.9.      Alere Inc.

15.10.  Quidel Corporation

15.11.  Creative Diagnostics

15.12.  Others

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion